News
-
-
-
-
Take Action For The International Thalassaemia Day 2021
INTERNATIONAL THALASSAEMIA DAY 2021 – 8 MAY ”Addressing Health Inequalities Across the Global Thalassaemia Community” Each year, individuals around the globe band together for one day of pure and empowering…
Read More » -
NEW PUBLICATION | TIF Recommendations Offer Guidance To Thalassaemia-Treating Physicians
The newly issued publication ‘Basic Recommendations in Brief for Treating Physicians’, based on and complementing the ‘Guidelines for the Management of Transfusion Dependent Thalassaemia (4th Edition – 2021)’, is an…
Read More » -
INTERNATIONAL THALASSAEMIA DAY | 8 May 2022
Every single one of us has the ability to make a difference, large or small, and together we can make real progress in raising valuable awareness about thalassaemia and its…
Read More » -
Oxbryta Increased Haemoglobin And Reduced Haemolysis in Adults and Adolescents With SCD
Global Blood Therapeutics, Inc. announced The Lancet Haematology has published the complete analysis of 72-week data from the Phase 3 HOPE Study of Oxbryta® (voxelotor) tablets in patients with sickle cell disease…
Read More » -
NUOVO WEBINAR: Il Valore Della Patient Advocacy Per Migliorare La Cura Delle Emoglobinopatie
L’obiettivo di questo incontro, che riunisce eminenti specialisti in emoglobinopatie ed esperti difensori dei pazienti provenienti dall’Italia e da altri paesi, è quello di evidenziare il valore fondamentale della patient…
Read More » -
NEW WEBINAR | Exploring The Value Of Patient Advocacy For Better Thalassaemia Care
The objective of this meeting, which brings together eminent haemoglobinopathies specialists and expert patient advocates from Italy and other countries, is to highlight the pivotal value of advocacy in enabling…
Read More » -
ROSARIO’S STORY | A True Champion of Resilience
Rosario was more than eager to recount this wonderful experience to TIF for the International Thalassaemia Day 2022 and share some inspiring messages with his peers. “It is important to…
Read More »